Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gwen A Huitt

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Clinics in Chest Medicine|February 14, 2015
Nontuberculous mycobacteriaGwen A Huitt, Charles L Daley
Community Genetics|April 1, 2008
Anxiety related to genetic testing for alpha-1 antitrypsin deficiency and cystic fibrosis in COPD and/or bronchiectasis patientsMarilyn E Coors, Arnold H Levinson, Gwen A Huitt
Respiratory Medicine|October 18, 2019
Efficacy and safety of tigecycline for Mycobacterium abscessus diseaseYong-Soo Kwon, Adrah Levin, Shannon H Kasperbauer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2004
Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseasesCharles A Peloquin, Shaun E Berning, Annette T Nitta, et al.
Scandinavian Journal of Infectious Diseases|July 27, 2007
Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophagesEdward D Chan, Aleksandra M Kaminska, Wendy Gill, et al.
American Journal of Respiratory and Critical Care Medicine|September 14, 2010
Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessusWon-Jung Koh, Kyeongman Jeon, Nam Yong Lee, et al.
Antimicrobial Agents and Chemotherapy|March 20, 2019
Species Distribution and Macrolide Susceptibility of <i>Mycobacterium fortuitum</i> Complex Clinical IsolatesSu-Young Kim, Seong Mi Moon, Byung Woo Jhun, et al.
American Journal of Respiratory and Critical Care Medicine|December 14, 2004
Late diagnosis defines a unique population of long-term survivors of cystic fibrosisDavid M Rodman, Jillian M Polis, Sonya L Heltshe, et al.
American Journal of Respiratory and Critical Care Medicine|May 8, 2010
Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosisJerry A Nick, Cathy S Chacon, Sara J Brayshaw, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 16, 2020
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice GuidelineCharles L Daley, Jonathan M Iaccarino, Christoph Lange, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Clinics in Chest Medicine|February 14, 2015
Nontuberculous mycobacteriaGwen A Huitt, Charles L Daley
Community Genetics|April 1, 2008
Anxiety related to genetic testing for alpha-1 antitrypsin deficiency and cystic fibrosis in COPD and/or bronchiectasis patientsMarilyn E Coors, Arnold H Levinson, Gwen A Huitt
Respiratory Medicine|October 18, 2019
Efficacy and safety of tigecycline for Mycobacterium abscessus diseaseYong-Soo Kwon, Adrah Levin, Shannon H Kasperbauer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2004
Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseasesCharles A Peloquin, Shaun E Berning, Annette T Nitta, et al.
Scandinavian Journal of Infectious Diseases|July 27, 2007
Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophagesEdward D Chan, Aleksandra M Kaminska, Wendy Gill, et al.
American Journal of Respiratory and Critical Care Medicine|September 14, 2010
Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessusWon-Jung Koh, Kyeongman Jeon, Nam Yong Lee, et al.
Antimicrobial Agents and Chemotherapy|March 20, 2019
Species Distribution and Macrolide Susceptibility of <i>Mycobacterium fortuitum</i> Complex Clinical IsolatesSu-Young Kim, Seong Mi Moon, Byung Woo Jhun, et al.
American Journal of Respiratory and Critical Care Medicine|December 14, 2004
Late diagnosis defines a unique population of long-term survivors of cystic fibrosisDavid M Rodman, Jillian M Polis, Sonya L Heltshe, et al.
American Journal of Respiratory and Critical Care Medicine|May 8, 2010
Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosisJerry A Nick, Cathy S Chacon, Sara J Brayshaw, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 16, 2020
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice GuidelineCharles L Daley, Jonathan M Iaccarino, Christoph Lange, et al.
Pageof 2